Frontlight ResearchEarly access
Frontotemporal dementia trials in New Zealand
1 of 1 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 1/2Taking peopleTrial of ARO-MAPT-SC in Healthy Participants and Participants With Early Alzheimer's Disease or Primary Tauopathies
- Where
- Grafton
- Age
- 18 years and over
- People
- 160 worldwide
- Run by
- Arrowhead Pharmaceuticals
See details and how to joinNCT07221344